US Stock MarketDetailed Quotes

GERN Geron

Watchlist
  • 1.650
  • 0.0000.00%
Close Mar 28 16:00 ET
  • 1.660
  • +0.010+0.60%
Post 18:35 ET
1.05BMarket Cap-6.11P/E (TTM)

About Geron Company

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Company Profile

SymbolGERN
Company NameGeron
Listing DateJul 30, 1996
Issue Price8.00
Founded1990
CEOMs. Dawn Carter Bir
MarketNASDAQ
Employees229
Fiscal Year Ends12-31
Address919 East Hillsdale Boulevard,Suite 250
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-473-7700

Company Executives

  • Name
  • Position
  • Salary
  • Dawn Carter Bir
  • Director, Interim President and Chief Executive Officer
  • 343.12K
  • Shannon T. Odam
  • Senior Vice President and Chief People Officer
  • --
  • Michelle Robertson
  • Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 2.47M
  • Melissa A. Kelly Behrs
  • Executive Vice President, Business Operations and Chief Alliance Officer
  • --
  • Scott A. Samuels
  • Executive Vice President, Chief Legal Officer and Corporate Secretary
  • 3.61M
  • James Ziegler
  • Executive Vice President and Chief Commercial Officer
  • --
  • Edward E. Koval
  • Executive Vice President and Chief Business Officer
  • --
  • Dr. Faye Feller, M.D.
  • Executive Vice President and Chief Medical Officer
  • --
  • Dr. Andrew J. Grethlein,PhD
  • Executive Vice President and Chief Operating Officer
  • 2.42M
  • Dr. Joseph Emile Eid
  • Executive Vice President, Research and Development
  • --
  • Elizabeth G. O’Farrell
  • Chairman of the Board and Lead Independent Director
  • 375.53K
  • John F. McDonald
  • Independent Director
  • 348.40K
  • Dr. V. Bryan Lawlis, PhD
  • Independent Director
  • 360.90K
  • Dr. Susan M. Molineaux, PhD
  • Independent Director
  • 345.90K
  • Dr. Robert J. Spiegel, F.A.C.P.,M.D.
  • Independent Director
  • 350.90K
  • Dr. Gaurav Aggarwal, M.D.
  • Independent Director
  • 290.82K

Market Insights

Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More